David A Scheinberg - Net Worth and Insider Trading
David A Scheinberg Net Worth
The estimated net worth of David A Scheinberg is at least $189,359 dollars as of 2025-07-25. David A Scheinberg is the Director of Progenics Pharmaceuticals Inc and owns about 46,185 shares of Progenics Pharmaceuticals Inc (PGNX) stock worth over $189,359. David A Scheinberg is also the Director of ContraFect Corp and owns about 20 shares of ContraFect Corp (CFRXQ) stock worth over $0. Details can be seen in David A Scheinberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David A Scheinberg has not made any transactions after 2014-07-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David A Scheinberg
David A Scheinberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David A Scheinberg owns 3 companies in total, including SELLAS Life Sciences Group Inc (SLS) , Progenics Pharmaceuticals Inc (PGNX) , and ContraFect Corp (CFRXQ) .
Click here to see the complete history of David A Scheinberg’s form 4 insider trades.
Insider Ownership Summary of David A Scheinberg
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SLS | SELLAS Life Sciences Group Inc | 2019-03-14 | director |
| PGNX | Progenics Pharmaceuticals Inc | 2019-07-11 | director |
| CFRXQ | ContraFect Corp | 2014-07-28 | director |
David A Scheinberg Latest Holdings Summary
David A Scheinberg currently owns a total of 2 stocks. Among these stocks, David A Scheinberg owns 46,185 shares of Progenics Pharmaceuticals Inc (PGNX) as of February 23, 2012, with a value of $189,359 and a weighting of 100%. David A Scheinberg also owns 20 shares of ContraFect Corp (CFRXQ) as of July 28, 2014, with a value of $0 and a weighting of 0%.
Latest Holdings of David A Scheinberg
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PGNX | Progenics Pharmaceuticals Inc | 2012-02-23 | 46,185 | 4.10 | 189,359 |
| CFRXQ | ContraFect Corp | 2014-07-28 | 20 | 0.00 | 0 |
Holding Weightings of David A Scheinberg
David A Scheinberg Form 4 Trading Tracker
According to the SEC Form 4 filings, David A Scheinberg has made a total of 0 transactions in Progenics Pharmaceuticals Inc (PGNX) over the past 5 years. The most-recent trade in Progenics Pharmaceuticals Inc is the sale of 1,250 shares on February 23, 2012, which brought David A Scheinberg around $12,500.
According to the SEC Form 4 filings, David A Scheinberg has made a total of 0 transactions in ContraFect Corp (CFRXQ) over the past 5 years. The most-recent trade in ContraFect Corp is the sale of 0 shares on July 28, 2014, which brought David A Scheinberg around $0.
Insider Trading History of David A Scheinberg
- 1
David A Scheinberg Trading Performance
David A Scheinberg Ownership Network
Ownership Network List of David A Scheinberg
Ownership Network Relation of David A Scheinberg
David A Scheinberg Owned Company Details
What does SELLAS Life Sciences Group Inc do?
Who are the key executives at SELLAS Life Sciences Group Inc?
David A Scheinberg is the director of SELLAS Life Sciences Group Inc. Other key executives at SELLAS Life Sciences Group Inc include EVP & Gen. Counsel & Corp. Sec. Barbara A Wood , VP & Finance & Corp Controller John Thomas Burns , and director & President and CEO Angelos M. Stergiou .
SELLAS Life Sciences Group Inc (SLS) Insider Trades Summary
Over the past 18 months, David A Scheinberg made no insider transaction in SELLAS Life Sciences Group Inc (SLS). Other recent insider transactions involving SELLAS Life Sciences Group Inc (SLS) include a net purchase of 20,000 shares made by Jane Wasman , a net purchase of 20,000 shares made by Katherine Bach Kalin , and a net purchase of 10,000 shares made by Van Nostrand Robert L .
In summary, during the past 3 months, insiders sold 0 shares of SELLAS Life Sciences Group Inc (SLS) in total and bought 50,000 shares, with a net purchase of 50,000 shares. During the past 18 months, 0 shares of SELLAS Life Sciences Group Inc (SLS) were sold and 50,000 shares were bought by its insiders, resulting in a net purchase of 50,000 shares.
SELLAS Life Sciences Group Inc (SLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
SELLAS Life Sciences Group Inc Insider Transactions
David A Scheinberg Mailing Address
Above is the net worth, insider trading, and ownership report for David A Scheinberg. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David A Scheinberg's mailing address is: New York Ny 10025.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
